NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
112,245,592
Total 13F shares
77,530,211
Share change
-124,038
Total reported value
$9,007,824,387
Put/Call ratio
140%
Price per share
$116.17
Number of holders
301
Value change
-$79,435,404
Number of buys
135
Number of sells
189

Quarterly Holders Quick Answers

What is CUSIP G6674U108?
CUSIP G6674U108 identifies NVCR - NovoCure Ltd - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q3 2021

As of 30 Sep 2021, NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by 301 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 77,530,211 shares. The largest 10 holders included Capital World Investors, Capital International Investors, BAILLIE GIFFORD & CO, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, CREDIT SUISSE AG/, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 301 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.